AMPH vs RUN · P/E 12, rev $732.0M vs P/E 6.0, rev $2.04B
Amphastar P (AMPH) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the AMPH and RUN stock pages for the full models.
Not investment advice.